Described by its leader as a $9-billion dollar corporation, the US National Institutes of Health are giving long-range corporate planning for biomedical research a try.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
NIH's first strategic plan debated. Nature 355, 573–574 (1992). https://doi.org/10.1038/355573a0
Issue Date:
DOI: https://doi.org/10.1038/355573a0